aluates Reports

$ 0.0

Automative

Sorafenib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-7K12447

Global Sorafenib Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Sorafenib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-7K12447

Report

September 2024

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Natco Pharma

Cipla Ltd

Mylan NV

Bayer

Sorafenib - Market Size

The global market for Sorafenib was estimated to be worth US$ 915 million in 2023 and is forecast to a readjusted size of US$ 786.5 million by 2030 with a CAGR of -2.2% during the forecast period 2024-2030

Sorafenib - Market

Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney cancer

Sorafenib is a targeted therapy used in the treatment of various cancers, including liver, kidney, and thyroid cancer. Factors driving market growth include the increasing incidence of these cancers, advancements in cancer treatment options, and the effectiveness of sorafenib in improving patient outcomes. The market is highly competitive, with several pharmaceutical companies manufacturing and marketing sorafenib. However, challenges such as high treatment costs, potential side effects, and the emergence of alternative therapies may hinder market growth. Nonetheless, the sorafenib market holds promising opportunities, driven by the growing global burden of cancer and the continuous research and development efforts to enhance the therapeutic potential of sorafenib.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sorafenib, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sorafenib by region & country, by Type, and by Application.

The Sorafenib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sorafenib.

Market Segmentation

Scope of Sorafenib - Market Report

Report Metric	Details
Report Name	Sorafenib - Market
Forecasted market size in 2030	US$ 786.5 million
Forecasted years	2024 - 2030
Segment by Type:	Patented Drugs Generic Drugs
Segment by Application	Kidney Cancer Liver Cancer Thyroid Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Natco Pharma, Cipla, Mylan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sorafenib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sorafenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sorafenib in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Sorafenib - Market size in 2030?

Ans: The Sorafenib - Market size in 2030 will be US$ 786.5 million.

Who are the main players in the Sorafenib - Market report?

Ans: The main players in the Sorafenib - Market are Bayer, Natco Pharma, Cipla, Mylan

What are the Application segmentation covered in the Sorafenib - Market report?

Ans: The Applications covered in the Sorafenib - Market report are Kidney Cancer, Liver Cancer, Thyroid Cancer, Other

What are the Type segmentation covered in the Sorafenib - Market report?

Ans: The Types covered in the Sorafenib - Market report are Patented Drugs, Generic Drugs

Recommended Reports

Cancer Drug Markets

Kidney & Renal Therapy

Targeted Cancer Therapies

1 Market Overview

1.1 Sorafenib Product Introduction

1.2 Global Sorafenib Market Size Forecast

1.2.1 Global Sorafenib Sales Value (2019-2030)

1.2.2 Global Sorafenib Sales Volume (2019-2030)

1.2.3 Global Sorafenib Sales Price (2019-2030)

1.3 Sorafenib Market Trends & Drivers

1.3.1 Sorafenib Industry Trends

1.3.2 Sorafenib Market Drivers & Opportunity

1.3.3 Sorafenib Market Challenges

1.3.4 Sorafenib Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Sorafenib Players Revenue Ranking (2023)

2.2 Global Sorafenib Revenue by Company (2019-2024)

2.3 Global Sorafenib Players Sales Volume Ranking (2023)

2.4 Global Sorafenib Sales Volume by Company Players (2019-2024)

2.5 Global Sorafenib Average Price by Company (2019-2024)

2.6 Key Manufacturers Sorafenib Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Sorafenib Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Sorafenib

2.9 Sorafenib Market Competitive Analysis

2.9.1 Sorafenib Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Sorafenib Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sorafenib as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Patented Drugs

3.1.2 Generic Drugs

3.2 Global Sorafenib Sales Value by Type

3.2.1 Global Sorafenib Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Sorafenib Sales Value, by Type (2019-2030)

3.2.3 Global Sorafenib Sales Value, by Type (%) (2019-2030)

3.3 Global Sorafenib Sales Volume by Type

3.3.1 Global Sorafenib Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Sorafenib Sales Volume, by Type (2019-2030)

3.3.3 Global Sorafenib Sales Volume, by Type (%) (2019-2030)

3.4 Global Sorafenib Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Kidney Cancer

4.1.2 Liver Cancer

4.1.3 Thyroid Cancer

4.1.4 Other

4.2 Global Sorafenib Sales Value by Application

4.2.1 Global Sorafenib Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Sorafenib Sales Value, by Application (2019-2030)

4.2.3 Global Sorafenib Sales Value, by Application (%) (2019-2030)

4.3 Global Sorafenib Sales Volume by Application

4.3.1 Global Sorafenib Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Sorafenib Sales Volume, by Application (2019-2030)

4.3.3 Global Sorafenib Sales Volume, by Application (%) (2019-2030)

4.4 Global Sorafenib Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Sorafenib Sales Value by Region

5.1.1 Global Sorafenib Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Sorafenib Sales Value by Region (2019-2024)

5.1.3 Global Sorafenib Sales Value by Region (2025-2030)

5.1.4 Global Sorafenib Sales Value by Region (%), (2019-2030)

5.2 Global Sorafenib Sales Volume by Region

5.2.1 Global Sorafenib Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Sorafenib Sales Volume by Region (2019-2024)

5.2.3 Global Sorafenib Sales Volume by Region (2025-2030)

5.2.4 Global Sorafenib Sales Volume by Region (%), (2019-2030)

5.3 Global Sorafenib Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Sorafenib Sales Value, 2019-2030

5.4.2 North America Sorafenib Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Sorafenib Sales Value, 2019-2030

5.5.2 Europe Sorafenib Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Sorafenib Sales Value, 2019-2030

5.6.2 Asia Pacific Sorafenib Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Sorafenib Sales Value, 2019-2030

5.7.2 South America Sorafenib Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Sorafenib Sales Value, 2019-2030

5.8.2 Middle East & Africa Sorafenib Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Sorafenib Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Sorafenib Sales Value

6.2.1 Key Countries/Regions Sorafenib Sales Value, 2019-2030

6.2.2 Key Countries/Regions Sorafenib Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Sorafenib Sales Value, 2019-2030

6.3.2 United States Sorafenib Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Sorafenib Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Sorafenib Sales Value, 2019-2030

6.4.2 Europe Sorafenib Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Sorafenib Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Sorafenib Sales Value, 2019-2030

6.5.2 China Sorafenib Sales Value by Type (%), 2023 VS 2030

6.5.3 China Sorafenib Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Sorafenib Sales Value, 2019-2030

6.6.2 Japan Sorafenib Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Sorafenib Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Sorafenib Sales Value, 2019-2030

6.7.2 South Korea Sorafenib Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Sorafenib Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Sorafenib Sales Value, 2019-2030

6.8.2 Southeast Asia Sorafenib Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Sorafenib Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Sorafenib Sales Value, 2019-2030

6.9.2 India Sorafenib Sales Value by Type (%), 2023 VS 2030

6.9.3 India Sorafenib Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bayer

7.1.1 Bayer Company Information

7.1.2 Bayer Introduction and Business Overview

7.1.3 Bayer Sorafenib Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Bayer Sorafenib Product Offerings

7.1.5 Bayer Recent Development

7.2 Natco Pharma

7.2.1 Natco Pharma Company Information

7.2.2 Natco Pharma Introduction and Business Overview

7.2.3 Natco Pharma Sorafenib Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Natco Pharma Sorafenib Product Offerings

7.2.5 Natco Pharma Recent Development

7.3 Cipla

7.3.1 Cipla Company Information

7.3.2 Cipla Introduction and Business Overview

7.3.3 Cipla Sorafenib Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Cipla Sorafenib Product Offerings

7.3.5 Cipla Recent Development

7.4 Mylan

7.4.1 Mylan Company Information

7.4.2 Mylan Introduction and Business Overview

7.4.3 Mylan Sorafenib Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Mylan Sorafenib Product Offerings

7.4.5 Mylan Recent Development

8 Industry Chain Analysis

8.1 Sorafenib Industrial Chain

8.2 Sorafenib Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Sorafenib Sales Model

8.5.2 Sales Channel

8.5.3 Sorafenib Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Natco Pharma

Cipla Ltd

Mylan NV

Bayer

List of Tables

Table 1. Sorafenib Market Trends

Table 2. Sorafenib Market Drivers & Opportunity

Table 3. Sorafenib Market Challenges

Table 4. Sorafenib Market Restraints

Table 5. Global Sorafenib Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Sorafenib Revenue Market Share by Company (2019-2024)

Table 7. Global Sorafenib Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Sorafenib Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Sorafenib Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Sorafenib Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Sorafenib Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Sorafenib

Table 13. Global Sorafenib Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sorafenib as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Sorafenib Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Sorafenib Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Sorafenib Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Sorafenib Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Sorafenib Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Sorafenib Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Sorafenib Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Sorafenib Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Sorafenib Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Sorafenib Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Sorafenib Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Sorafenib Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Sorafenib Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Sorafenib Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Sorafenib Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Sorafenib Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Sorafenib Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Sorafenib Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Sorafenib Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Sorafenib Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Sorafenib Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Sorafenib Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Sorafenib Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Sorafenib Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Sorafenib Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Sorafenib Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Sorafenib Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Sorafenib Sales Value by Region (2019-2024) & (%)

Table 44. Global Sorafenib Sales Value by Region (2025-2030) & (%)

Table 45. Global Sorafenib Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Sorafenib Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Sorafenib Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Sorafenib Sales Volume by Region (2019-2024) & (%)

Table 49. Global Sorafenib Sales Volume by Region (2025-2030) & (%)

Table 50. Global Sorafenib Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Sorafenib Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Sorafenib Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Sorafenib Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Sorafenib Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Sorafenib Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Sorafenib Sales Volume, (2025-2030) & (K Units)

Table 57. Bayer Company Information

Table 58. Bayer Introduction and Business Overview

Table 59. Bayer Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Bayer Sorafenib Product Offerings

Table 61. Bayer Recent Development

Table 62. Natco Pharma Company Information

Table 63. Natco Pharma Introduction and Business Overview

Table 64. Natco Pharma Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Natco Pharma Sorafenib Product Offerings

Table 66. Natco Pharma Recent Development

Table 67. Cipla Company Information

Table 68. Cipla Introduction and Business Overview

Table 69. Cipla Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Cipla Sorafenib Product Offerings

Table 71. Cipla Recent Development

Table 72. Mylan Company Information

Table 73. Mylan Introduction and Business Overview

Table 74. Mylan Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Mylan Sorafenib Product Offerings

Table 76. Mylan Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Sorafenib Downstream Customers

Table 80. Sorafenib Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Sorafenib Product Picture

Figure 2. Global Sorafenib Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Sorafenib Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Sorafenib Sales Volume (2019-2030) & (K Units)

Figure 5. Global Sorafenib Sales Price (2019-2030) & (USD/Unit)

Figure 6. Sorafenib Report Years Considered

Figure 7. Global Sorafenib Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Sorafenib Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sorafenib Revenue in 2023

Figure 10. Sorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Patented Drugs Picture

Figure 12. Generic Drugs Picture

Figure 13. Global Sorafenib Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Sorafenib Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Sorafenib Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Sorafenib Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Sorafenib Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Kidney Cancer

Figure 19. Product Picture of Liver Cancer

Figure 20. Product Picture of Thyroid Cancer

Figure 21. Product Picture of Other

Figure 22. Global Sorafenib Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Sorafenib Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Sorafenib Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Sorafenib Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Sorafenib Price by Application (2019-2030) & (USD/Unit)

Figure 27. North America Sorafenib Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Sorafenib Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Sorafenib Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Sorafenib Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Sorafenib Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Sorafenib Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Sorafenib Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Sorafenib Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Sorafenib Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Sorafenib Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Sorafenib Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Sorafenib Sales Volume (%), (2019-2030)

Figure 39. United States Sorafenib Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Sorafenib Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Sorafenib Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Sorafenib Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Sorafenib Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Sorafenib Sales Value by Application (%), 2023 VS 2030

Figure 45. China Sorafenib Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Sorafenib Sales Value by Type (%), 2023 VS 2030

Figure 47. China Sorafenib Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Sorafenib Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Sorafenib Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Sorafenib Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Sorafenib Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Sorafenib Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Sorafenib Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Sorafenib Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Sorafenib Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Sorafenib Sales Value by Application (%), 2023 VS 2030

Figure 57. India Sorafenib Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Sorafenib Sales Value by Type (%), 2023 VS 2030

Figure 59. India Sorafenib Sales Value by Application (%), 2023 VS 2030

Figure 60. Sorafenib Industrial Chain

Figure 61. Sorafenib Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nilotinib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Regofinil Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dovitinib Market Research Report 2024

Stomach Cancer and Gastric Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gleevec Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radotinib Market Research Report 2024

Global Sorafenib API Market Research Report 2025

Sorafenib Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sorafenib Tosylate Tablets Market Research Report 2024

Global Cancer Janus Kinase Inhibitors Market Research Report 2024

Global Pazopanib API Market Research Report 2025

PD L1 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nutritional Supplements for Chronic Kidney Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Quizartinib Market Research Report 2024

Anlotinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Advanced Renal Cell Carcinoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kinase Inhibitors Market Insights Forecast to 2030

Stomach Cancer and Gastric Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions